| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.5M | +454.7% |
| Cost of Revenue | $7.6M | +487.9% |
| Gross Profit | $906K | +276.5% |
| R&D Expense | $2.3M | +37.2% |
| SG&A Expense | $14.6M | +5.4% |
| Operating Income | -$15.5M | -4.9% |
| Pre-tax Income | -$16.2M | -8.3% |
| Net Income | -$16.2M | -8.3% |
| EPS (Basic) | -$5.84 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.9M | +45.1% |
| Accounts Receivable | $43K | -90.8% |
| Inventory | $5.2M | +42.9% |
| Current Assets | $10.5M | +14.8% |
| Total Assets | $25.7M | -0.8% |
| Current Liabilities | $3.2M | -55.7% |
| Long-term Debt | $5.3M | -0.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.1M | +15.0% |
| Capital Expenditures | $528K | -85.7% |
| Investing Cash Flow | -$528K | +85.9% |
| Financing Cash Flow | $12.2M | +174.9% |
| Free Cash Flow | -$10.7M | +31.7% |
| -595.2% |
| EPS (Diluted) | -$5.84 | -595.2% |
| Total Liabilities |
| $8.3M |
| +7.0% |
| Stockholders' Equity | $17.4M | -4.2% |